A novel donor-derived cell-free DNA assay for the detection of acute rejection in heart transplantation
Paul Kim(Profectus Biosciences (United States)), Josef Stehlik(Intermountain Medical Center), Omar Wever‐Pinzon(University of Utah), Jonathan Sternberg(Natera (United States)), Navchetan Kaur(Natera (United States)), Michael Olymbios(Natera (United States)), Gordon Fehringer(Natera (United States)), Ryan Swenerton(Natera (United States)), Yen-An Chen(Natera (United States)), Eric Adler(UC San Diego Health System), Paul R. Billings(Natera (United States)), Ebad Ahmed(Natera (United States)), Nathan L. Liang(Natera (United States)), Alfonso Siu(University of Utah), Zachary Demko(Natera (United States))
Cited by 71
Related Papers
Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stages I to III Colorectal Cancer
|JAMA Oncology|2019|992
Early Detection of Metastatic Relapse and Monitoring of Therapeutic Efficacy by Ultra-Deep Sequencing of Plasma Cell-Free DNA in Patients With Urothelial Bladder Carcinoma
|Journal of Clinical Oncology|2019|540
HF STATS 2024: Heart Failure Epidemiology and Outcomes Statistics An Updated 2024 Report from the Heart Failure Society of America
|Journal of Cardiac Failure|2024|357
Survivin and molecular pathogenesis of colorectal cancer
|The Lancet|2003|322
Inhibition of melanoma tumor growth <i>in vivo</i> by survivin targeting
|Proceedings of the National Academy of Sciences|2001|285